# IPCURE

> targeted caspase therapeutic development

Business model and tags: Pharma & life sciences, Has in-house R&D

## About IPCURE

Development of innovative drugs targeting caspase enzymes to treat neurodegenerative, metabolic, and inflammatory diseases, improving patient quality of life.

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 1–10 employees
- **Founded**: 2023
- **Revenue**: $2.9M – $22.9M (Tamtam estimate)
- **Website**: [ipcure.life](https://www.ipcure.life/)
- **LinkedIn**: [linkedin.com/company/ipcure-biotech](https://www.linkedin.com/company/ipcure-biotech)

## IPCURE at a glance

IPCURE is a company in the Biotechnology Research industry.

IPCURE was founded in 2023.

IPCURE has 1–10 employees.

IPCURE's revenue is $2.9M – $22.9M (Tamtam estimate).

## Frequently asked questions about IPCURE

### What is IPCURE's revenue?

Tamtam estimates IPCURE's annual revenue at $2.9M – $22.9M.

### How many employees does IPCURE have?

IPCURE has 1–10 employees.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/ipcure